Atezolizumab Now Also Approved for Front-Line NSCLC Atezolizumab Now Also Approved for Front-Line NSCLC
The immunotherapy has received FDA approval for an expanded indication for use in combination in nonsmall cell lung cancer.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer